Chemistry And The Human Body

Why Most People Get Biochemistry Wrong From Day One

I spent a semester as a teaching assistant for an introductory human biochemistry course, and without fail, every single student walked into that room thinking the body runs on a set of simple chemical equations written on a whiteboard somewhere. They weren't wrong exactly, but the gap between the textbook and what actually happens inside a living organism is enormous and tends to trip people up repeatedly. The fundamental issue is that chemistry and the human body don't exist in separate categories. Your stomach acid breaking down a protein, the electron transport chain firing in your mitochondria, the way your liver processes a dose of ibuprofen — all of this is chemistry. But it's chemistry operating under conditions that most general chemistry courses barely mention. Temperature fluctuations, pH gradients across membranes, enzyme concentrations measured in nanomolar ranges, and the fact that nearly every reaction in your body happens inside a microscopic aqueous environment packed with other molecules that want to interfere. That changes everything about how you should think about reactions and equilibria.

Chemistry And The Human Body: What Actually Happens

When you study metabolism in a standard course, you're looking at isolated pathways drawn as clean arrows from point A to point B. Glycolysis, the Krebs cycle, beta oxidation — these are real, but they are presented as if each step happens in a vacuum. In reality, these pathways share intermediates, compete for the same enzymes, and are regulated by feedback mechanisms that can shut an entire pathway down in seconds if the cell has enough ATP. I remember a specific problem that came up when I was working through a case study on lactic acidosis. A patient had been running a marathon in ninety-degree weather and ended up with a blood pH of 7.1. The textbook explanation says lactate builds up because pyruvate gets shunted away from the Krebs cycle when oxygen delivery can't keep up with demand. That's correct, but it's also incomplete. The real clinical complication wasn't just the lactate — it was the hydrogen ions released alongside it, which depressed hemoglobin's oxygen binding affinity through the Bohr effect. So the patient wasn't just acidotic, they were simultaneously struggling to unload oxygen at the tissue level. The chemistry connects in ways that aren't obvious until you see it play out in a real patient.

How Reaction Kinetics Actually Work in Living Systems

Chemical kinetics in a test tube follows predictable rate laws. You measure concentration changes over time, you plot the data, you get a clean curve. Inside a cell, those same reactions are subject to molecular crowding, compartmentalization, and allosteric regulation that makes simple rate equations almost useless on their own. The Michaelis-Menten model you learned about is a starting point, not a complete description. One thing that catches people off guard is how much enzyme concentration matters compared to what initial chemistry classes emphasize. In vitro, you can often assume substrate is in excess and the enzyme is the limiting factor. In vivo, both are tightly controlled and usually present in comparable effective concentrations. This means small changes in enzyme expression levels — things like induction through gene upregulation — can have outsized effects on metabolic flux. Your body does this constantly. After a high-carbohydrate meal, insulin signaling increases the expression of glucokinase in the liver, which shifts glucose processing toward glycogen storage rather than letting it pass through to the bloodstream. Another practical detail that gets glossed over: most biochemical reactions are reversible, and the direction they actually proceed depends on the mass action ratio, not just the standard free energy change. The standard delta G values you see in tables assume one-molar concentrations of everything, which is nowhere close to physiological conditions. When you recalculate using actual intracellular concentrations, some reactions that look spontaneous on paper are actually running near equilibrium in the cell, meaning they can flip direction depending on local conditions. This is especially relevant for the creatine kinase reaction in muscle tissue, where the same enzyme supports both ATP generation during contraction and ATP storage during recovery.

Acid-Base Chemistry: The Part Nobody Prepares You For

The Henderson-Hasselbalch equation is straightforward until you try to apply it to blood. The bicarbonate buffer system in plasma is elegant on paper, but in practice it's an open system. Your lungs constantly remove CO2, and your kidneys regulate bicarbonate reabsorption and excretion independently. This means the classic buffer equation needs modification to account for the fact that you're not working in a closed container. I encountered this directly when reviewing arterial blood gas readings with a colleague who was new to critical care. She was calculating the expected bicarbonate for a given pCO2 using the standard formula and getting numbers that didn't match the lab values. The discrepancy wasn't a calculation error. It was the strong ion difference — the gap between fully dissociated cations and anions in the plasma — which the traditional Henderson-Hasselbalch approach for the bicarbonate system doesn't capture. The Stewart approach to acid-base chemistry, which treats strong ions and weak acids as the primary determinants of pH, gave the correct answer. Most introductory courses don't cover this, and it's one of those gaps that becomes immediately obvious when you're reading actual clinical data.

Drug Metabolism and Phase Reactions

Understanding how the body processes foreign chemicals requires knowing both Phase I and Phase II metabolism, and more importantly, understanding why the distinction matters practically. Phase I reactions — mainly cytochrome P450 oxidations — introduce or expose functional groups on drug molecules. Phase II reactions attach polar molecules like glucuronic acid or sulfate to make those intermediates water-soluble enough for excretion. The key insight that most people miss is that Phase I metabolism can sometimes activate a prodrug into its active form, which is exactly how drugs like codeine work. Codeine itself has minimal analgesic effect. It relies on CYP2D6 to convert it into morphine in the liver. But CYP2D6 activity varies enormously between individuals due to genetic polymorphisms. Some people are ultrarapid metabolizers and experience dangerous morphine levels from standard codeine doses. Others are poor metabolizers and get essentially no pain relief. This isn't theoretical — it's a documented clinical issue that affects dosing decisions regularly. Another practical consideration: enzyme induction. If someone is taking rifampin for a bacterial infection and also takes a medication metabolized by CYP3A4, the rifampin will upregulate that enzyme over several days, potentially reducing the second drug's effectiveness by half or more. This kind of interaction doesn't show up in a single-dose pharmacokinetic study. It requires steady-state conditions and time-dependent enzyme expression changes. I learned this the hard way when reviewing a case where a patient's antiretroviral therapy appeared to fail despite perfect adherence, and the missing piece was a concurrently prescribed antibiotic that had induced the metabolism of the antiretroviral drugs.

Redox Chemistry and Cellular Energy

The electron transport chain is perhaps the most important set of redox reactions in human biology, and it's also one of the most misunderstood. The simplified version taught in intro courses shows electrons flowing from NADH to oxygen through a series of protein complexes, with proton pumping at each step. This is accurate enough for a diagram, but it leaves out several details that matter when you're actually thinking about how the system behaves under stress or disease. One of those details is proton leak. Not all the protons pumped by the electron transport chain flow back through ATP synthase. A small fraction leaks across the inner mitochondrial membrane through uncoupling proteins and through the membrane itself. This isn't a design flaw — it's a regulatory feature. Brown adipose tissue uses uncoupling protein 1 to generate heat instead of ATP, which is essential for thermogenesis in newborns and hibernating mammals. In adults, mild uncoupling occurs continuously and represents a significant portion of basal metabolic rate. When people talk about metabolism and calorie burning, this is part of what's actually happening at the molecular level. A more serious concern is reactive oxygen species production. The electron transport chain is inherently leaky. A small percentage of electrons escape the chain and reduce oxygen directly to superoxide, primarily at complexes I and III. Under normal conditions, superoxide dismutase and other antioxidant systems handle this. But during ischemia-reperfusion injury — when blood flow is restored after a period of oxygen deprivation — there's a burst of superoxide production that overwhelms the antioxidant defenses. This is a major contributor to tissue damage after heart attacks and strokes. The chemistry is well understood. Managing it clinically remains difficult.

Precision Medicine and Biochemical Variation

The field of pharmacogenomics exists because the chemistry between drugs and human bodies is not uniform. Genetic variation in drug-metabolizing enzymes, transport proteins, and receptor targets means that two people can respond very differently to the same compound at the same dose. This isn't a rare edge case. It's the norm, and it's becoming increasingly relevant as personalized treatment options expand. Testing for CYP2C19 variants before prescribing clopidogrel is now standard practice in many cardiology departments. Clopidogrel is a prodrug that requires CYP2C19 for activation. Patients with loss-of-function alleles have reduced conversion to the active metabolite and higher rates of stent thrombosis. The alternative is to use a different antiplatelet agent that doesn't depend on that metabolic pathway. This is a concrete example of chemistry and human genetics intersecting in a way that directly affects treatment outcomes. There are limitations to this approach, and it's worth being honest about them. Genetic testing doesn't capture everything. Environmental factors, concurrent medications, organ function, and age all influence drug response independently of genotype. A patient with normal CYP2D6 function who also has severe liver cirrhosis will metabolize drugs differently than a healthy person with the same genotype. Genetics is one variable in a complex system, not a standalone answer.

Practical Takeaways

If you're trying to understand how chemistry operates in the human body, start with the recognition that the body is an open, dynamic, highly regulated system. Equations from a general chemistry textbook describe idealized conditions. Living systems operate far from those ideals, and the deviations are where the interesting and important biology happens. Pay attention to concentration gradients across membranes. Pay attention to enzyme regulation and how it changes over time. Pay attention to the difference between what a reaction can do in a test tube and what it actually does inside a cell. These distinctions matter more than memorizing pathways, and they're the things that separate people who can apply biochemical knowledge from people who can only recite it.